Douglas Mccloskey is a founder and AI-driven life sciences entrepreneur with 11 years of experience building digital and physical twins to accelerate drug discovery, automate R&D workflows, and engineer cell factories. He has led multidisciplinary teams at organizations from DTU and BioMed X (Sanofi-sponsored) to startups like AliveX and his current venture Biom8er, translating single-cell omics, agentic AI, and knowledge graphs into predictive platforms for clinical efficacy and biomarker discovery. Comfortable at the intersection of software engineering and wet-lab automation, he has hands-on contributions to high-performance bioinformatics codebases (e.g., algorithm work on the OpenMS mass-spectrometry project) and has deployed Agile processes across academic and industry collaborations. Douglas combines deep technical rigor from a PhD in Bioengineering with founder-level product and fundraising experience, making him a practical leader for startups seeking to industrialize intelligent life-science workflows.
Contributions:5 reviews, 446 commits, 37 PRs in 5 years
Contributions summary:Douglas primarily focused on implementing and refining core algorithms within the OpenMS project. Their contributions involved developing and adding new methods for calculating peak shape metrics and related quality control measures. The user's work included defining new methods in the header files and providing the corresponding method bodies.
Contributions:22 pushes, 1 branch, 2 comments in 7 years 10 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.